C-Rad AB (publ) reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 98.8 million compared to SEK 77.4 million a year ago. Net income was SEK 4.2 million compared to SEK 11.4 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.65 SEK | +0.36% | +8.89% | -1.30% |
May. 06 | C-RAD Partners with RaySearch Laboratories to Improve Radiation Therapy | MT |
May. 04 | RaySearch Laboratories AB and C-RAD Sign Collaboration Agreement | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.30% | 129M | |
+12.06% | 225B | |
+12.07% | 186B | |
+13.88% | 135B | |
+27.12% | 107B | |
+0.91% | 63.56B | |
+6.74% | 51.32B | |
+13.39% | 51.04B | |
+8.81% | 43.3B | |
+4.14% | 36.99B |
- Stock Market
- Equities
- CRAD B Stock
- News C-Rad AB
- C-Rad AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022